Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-10 · accession 0001209191-22-028706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-12 | 2022-05-10+ | TVTX | Calvin Sandra | SVP, CAO | S - Sale | $21.72 | -881 | 35.7K | -2% | -$19.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | S | D | 436 | $21.51 | 36,178 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-11 | S | D | 445 | $21.92 | 35,733 | D | — | — |